Here, we demonstrated the preventive efficacy of the MUC1 DNA vaccine when combined with purified autologous bone-marrow-derived DCs (BMDCs) against a colitis-associated colorectal tumor in MUC1.Tg mice. This evidence concerns the gene MUC1 and colorectal neoplasm.